Abstract
Nature 402, 297–301 (1999). In this paper, the authors omitted the reference to the published synthetic pathway1 by which the selective GluR5 kainate receptor antagonist LY382884 may be made.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.